Edition:
India

Nordic Nanovector ASA (NANOV.OL)

NANOV.OL on Oslo Stock Exchange

50.90NOK
18 May 2018
Change (% chg)

kr2.04 (+4.18%)
Prev Close
kr48.86
Open
kr48.86
Day's High
kr51.50
Day's Low
kr48.40
Volume
207,832
Avg. Vol
370,150
52-wk High
kr113.00
52-wk Low
kr37.26

Latest Key Developments (Source: Significant Developments)

Nordic Nanovector: Ludvik Sandnes To Step Down As Chairman
Tuesday, 8 May 2018 

May 8 (Reuters) - Nordic Nanovector ASA ::LUDVIK SANDNES HAS INFORMED THE NOMINATION COMMITTEE THAT HE WISHES TO STEP DOWN AS CHAIRMAN.THE NOMINATION COMMITTEE PROPOSES THAT LUDVIK SANDNES IS RE-ELECTED AS CHAIRMAN OF THE BOARD UNTIL A NEW CHAIRPERSON HAS BEEN ELECTED.THE ANNUAL GENERAL MEETING OF NORDIC NANOVECTOR ASA WILL BE HELD ON 30 MAY.  Full Article

‍Nordic Nanovector Provides Update On Paradigme Clinical Trial​
Thursday, 5 Apr 2018 

April 4 (Reuters) - Nordic Nanovector ASA ::‍NORDIC NANOVECTOR PROVIDES UPDATE ON PARADIGME CLINICAL TRIAL​.‍RESULTS FROM PARADIGME ARE TARGETED FOR 1H 2020 (PREVIOUSLY 2H 2019) AND FIRST REGULATORY FILING IN 2020.‍GUIDANCE IS UNCHANGED FOR PREVIOUSLY REPORTED MILESTONES FOR ARCHER-1 AND LYMRIT 37-05, BOTH ANTICIPATED IN 2H 2018​.FINANCIAL RESOURCES ARE EXPECTED TO BE SUFFICIENT TO REACH DATA READ-OUT FROM PARADIGME​.  Full Article

‍Nordic Nanovector Says Luigi Costa Will Step Down As CEO
Thursday, 5 Apr 2018 

April 4 (Reuters) - Nordic Nanovector ASA ::‍NORDIC NANOVECTOR ANNOUNCES THAT LUIGI COSTA WILL STEP DOWN AS CHIEF EXECUTIVE OFFICER​.NORDIC NANOVECTOR ASA SAYS ‍COSTA HAS AGREED TO BE AVAILABLE TO BOARD UNTIL END OF JULY 2018​.  Full Article

Nordic Nanovector Q3 comprehensive loss widens to NOK 85.9 mln​
Wednesday, 22 Nov 2017 

Nov 22 (Reuters) - NORDIC NANOVECTOR ASA ::‍REVENUES FOR Q3 AMOUNTED TO NOK 0.1 MILLION (NOK 0.1 MILLION)​.‍TOTAL OPERATING EXPENSES FOR Q3 WERE NOK 72.7 MILLION (NOK 50.4 MILLION)​.‍COMPREHENSIVE LOSS FOR Q3 AMOUNTED TO NOK 85.9 MILLION (LOSS OF NOK 61.3 MILLION)​.  Full Article

Nordic Nanovector Q2 operating loss widens NOK 48.1 million
Wednesday, 24 Aug 2016 

Nordic Nanovector ASA : Q2 total operating revenue 0.1 million Norwegian crowns ($12,170) versus 0.1 million crowns year ago . Q2 operating loss 48.1 million crowns versus loss 51.1 million crowns year ago .Current cash resources are expected to be sufficient to reach first regulatory submission for Betalutin in FL in the first half of 2019.  Full Article

Nordic Nanovector and AREVA Med enter into collaboration
Tuesday, 28 Jun 2016 

Nordic Nanovector ASA : Says the company and AREVA Med to investigate potential of lead-212 conjugated anti-CD37 antibody for treating leukaemias . Will provide its chimeric anti-CD37 antibody (NNV003) and its expertise in antibody radionuclide conjugate (ARC) development . AREVA Med will provide expertise in production of 212pb . Preclinical studies will be conducted at AREVA Med's facility in Plano, Texas, USA .Has option to license any resulting ARCS for further development and AREVA med has option to license use of CD37-targeting antibodies for its own purposes.  Full Article